Company research
Bain Capital GSS Investment Corp.
CIK 2064355Updated Oct 6, 2026
BCSS price & chart
Loading TradingView…
NYSE:BCSS on TradingView ↗In the news
No coverage from other publishers is available.
Financials
FY 2025 · USDSource
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| AssetsUSD | 9,607,900Source | 474,170,404Source | — | 469,963,848Source | — | 465,840,596Source |
| Current assets: | ||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 0Source | 0Source | — | 0Source | — | 0Source |
| Assets, CurrentUSD | 2,000,000Source | 892,190Source | — | 932,225Source | — | 1,023,538Source |
| LIABILITIES AND EQUITY | ||||||
| LiabilitiesUSD | 9,654,068Source | 16,755,874Source | — | 16,501,797Source | — | 16,391,711Source |
| Stockholders’ equity: | ||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | — | 0Source | — | 0Source |
| Additional Paid in CapitalUSD | 23,850Source | 0Source | — | 0Source | — | 0Source |
| Retained Earnings (Accumulated Deficit)USD | -71,168Source | -15,808,599Source | — | -15,458,162Source | — | -15,200,438Source |
| Stockholders' Equity Attributable to ParentUSD | -46,168Source | -15,807,359Source | -25,568Source | -15,456,922Source | 4,392Source | -15,199,198Source |
| Liabilities and EquityUSD | 9,607,900Source | 474,170,404Source | — | 469,963,848Source | — | 465,840,596Source |
| Current liabilities: | ||||||
| Liabilities, CurrentUSD | — | 655,874Source | — | 401,797Source | — | 291,711Source |
| Additional Financial Items | ||||||
| Accrued Liabilities, CurrentUSD | 20,600Source | 465,562Source | — | 316,797Source | — | 202,210Source |
cash flow · annual statements
| Line item | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 |
|---|---|---|---|---|---|---|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 2,000,000Source | 622,015Source | 0Source | 637,186Source | 0Source | 784,949Source |
| Increase (Decrease) in Accounts Payable | — | — | —Source | —Source | — | — |
| Net Cash Provided by (Used in) Operating Activities | — | — | —Source | —Source | — | — |
| Net Cash Provided by (Used in) Financing Activities | — | — | —Source | —Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | —Source | —Source | — | — |
| Share-based Payment Arrangement, Expense | — | —Source | — | — | — | — |
| General and Administrative Expense | —Source | —Source | —Source | —Source | — | — |
| Net Income (Loss) Attributable to Parent | —Source | —Source | —Source | —Source | — | — |
income statement · annual statements
| Line item | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 |
|---|---|---|---|---|
| Operating Income (Loss) | —Source | —Source | —Source | —Source |
| Net Income (Loss) Attributable to Parent | —Source | —Source | —Source | —Source |
| Weighted Average Number of Shares Outstanding, Diluted | —Source | — | — | — |
| General and Administrative Expense | —Source | —Source | —Source | —Source |
| Other Income | — | —Source | —Source | —Source |